CMB 1.20% 42.0¢ cambium bio limited

That's great news, and I would have liked to hear more about...

  1. 172 Posts.
    lightbulb Created with Sketch. 52
    That's great news, and I would have liked to hear more about this patent for MSC treatments developed by others. For instance, if this patent can be used to monitor Mesoblast (ASX:MSB) efficiency, this could lead to a partnership with the leader in this field, and therefore bring attention to RGS from MSB investors.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.